Baxion
Screening
Tags
Alerts
Theme
Unicycive Therapeutics, Inc.
UNCY
·
NASDAQ
·
$7.06
Share Price as of 11/2
·
$152M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/12/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/30/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
09/29/26
8-K
Current report
09/28/26
8-K
Current report
08/12/26
8-K
Current report
07/02/26
8-K
Current report
06/22/26
Prospectuses and Registrations
Filter
S-3
Shelf registration
06/05/26
S-8
Registration of securities for employees
05/06/26
424B5
Prospectus supplement
11/14/25
424B5
Prospectus supplement
06/13/25
S-8
Registration of securities for employees
04/01/25
Proxies
Filter
DEFA14A
Additional proxy materials
06/22/26
DEF 14A
Definitive proxy
04/30/26
DEFA14A
Additional proxy materials
04/30/26
DEFA14A
Additional proxy materials
06/09/25
DEFA14A
Additional proxy materials
05/22/25
Ownership
Filter
Form 4
Insider transaction
10/29/26
Form 3
Initial insider ownership
10/01/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G
Beneficial ownership
07/30/26
Other
Filter
EFFECT
Request for effectiveness
06/15/26
CORRESP
Correspondence with the SEC
06/11/26
UPLOAD
Letter from the SEC
06/11/26
ARS
Annual report to shareholders
04/30/26
ARS
Annual report to shareholders
04/30/25
Latest Filings
Filter
8-K
Current report
09/29/26
8-K
Current report
09/28/26
10-Q
Q2 ended 06/30/26
08/12/26
8-K
Current report
08/12/26
8-K
Current report
07/02/26
Ownership
Filter
Form 4
Insider transaction
10/29/26
Form 3
Initial insider ownership
10/01/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G
Beneficial ownership
07/30/26